Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06729983 · ClinicalTrials.gov registry record · NA
Prophylactic Conjoint Tendon Lengthening During Reverse Shoulder Arthroplasty Outcomes
A NA study of Osteoarthritis Shoulder, sponsored by Nickolas Garbis.
- Recruiting
- Registry status
- NA
- Development phase
- 110
- Enrollment target
- 1
- Study location
NCT06729983: Recruiting NA study of Osteoarthritis Shoulder, sponsored by Nickolas Garbis.
NCT06729983 is a NA study of Osteoarthritis Shoulder that is actively recruiting participants, run by Nickolas Garbis. The registered enrollment target is 110 participants, below the 356-participant average among 8 other Osteoarthritis Shoulder trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06729983, a NA study of Osteoarthritis Shoulder, is actively recruiting participants, sponsored by Nickolas Garbis.
- RECRUITING
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
- 1
- Study location
Study Summary
Some patients may experience persistent pain in the front of their shoulder after reverse shoulder replacement. One of the possible reasons for this is that the surgery causes a change in the alignment of the shoulder joint, which may cause increased tension and compression on one of the biceps tendon called the conjoint tendon. The purpose of this study is to evaluate whether conjoint tendon lengthening, a surgical procedure that involves cutting and lengthening the conjoint tendon in order to reduce tension and compression, is able to prevent or reduce the risk of anterior shoulder pain at one year after surgery.
Primary Outcome
The ASES is a 100-point scale that consists of two dimensions: pain and activities of daily living. There is one pain scale worth 50 points and ten activities of daily living worth 50 points. The higher the points the better the outcome.
Conditions Studied
Interventions
- PROCEDURE Prophylactic Conjoint Tendon Lengthening
- PROCEDURE Standard Reverse Shoulder Arthroplasty
Study Locations (1)
Illinois
- Loyola Outpatient Center - Maywood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2025-03 |
| Est. Completion | 2029-03 |
| Phase | NA |
What NCT06729983 shows while recruiting
NCT06729983 is an interventional study that assigns participants to a tested intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, below the 356-participant average among 8 other Osteoarthritis Shoulder trials with a reported enrollment target (69% lower).
The record links to 1 condition, with Osteoarthritis Shoulder appearing as the primary indexed condition, and to 2 interventions - of which Prophylactic Conjoint Tendon Lengthening is the first listed.
NCT06729983 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06729983 about?
NCT06729983 is a clinical study titled "Prophylactic Conjoint Tendon Lengthening During Reverse Shoulder Arthroplasty Outcomes". Some patients may experience persistent pain in the front of their shoulder after reverse shoulder replacement. One of the possible reasons for this is that the surgery causes a change in the alignment of the shoulder joint, which may cause increased tension and compression on one of the biceps tend...
What is the current status of trial NCT06729983?
This trial is currently recruiting. It is a NA study. The enrollment target is 110 participants. The study started on 2025-03. Estimated completion is 2029-03.
What conditions does trial NCT06729983 study?
This clinical trial studies the following conditions: Osteoarthritis Shoulder.
What interventions are being tested in trial NCT06729983?
The interventions under investigation include: Prophylactic Conjoint Tendon Lengthening (PROCEDURE), Standard Reverse Shoulder Arthroplasty (PROCEDURE).
Who is sponsoring clinical trial NCT06729983?
This trial is sponsored by Nickolas Garbis, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06729983 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis Shoulder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06729983's enrollment target sits among peer trials
110 6th of 8 higher than 3 of 8 other Osteoarthritis Shoulder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Osteoarthritis Shoulder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Catalyst CSR Shoulder System for Semi or Total Shoulder Arthroplasty
RECRUITING · NA
-
Effectiveness of Occupation-Based Intervention Compared With Therapeutic Exercise for Older Adults With Shoulder OA.
COMPLETED · NA
-
FX Shoulder Solutions Retrospective / Prospective Clinical Study
RECRUITING
-
The Effect of Micro Fragmented Adipose Tissue (MFAT) on Shoulder Osteoarthritis
RECRUITING · Phase 1
-
FX Shoulder Prospective Clinical Study
RECRUITING
-
Embo Registry; National Registry for Artery Embolization
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia